EP 0868911 A3 20001206 - Rapamycin formulations for oral administration
Title (en)
Rapamycin formulations for oral administration
Title (de)
Rapamycin enthaltende Formulierungen zur oralen Verabreichung
Title (fr)
Formulations de rapamycine pour administration orale
Publication
Application
Priority
US 81501597 A 19970314
Abstract (en)
[origin: EP0868911A2] This invention provides rapamycin solid dosage unit which comprises a core and a sugar overcoat, said sugar overcoat comprising rapamycin, one or more surface modifying agents, one or more sugars, and optionally one or more binders.
IPC 1-7
IPC 8 full level
A61J 3/10 (2006.01); A61K 9/20 (2006.01); A61K 9/36 (2006.01); A61K 9/28 (2006.01); A61K 31/395 (2006.01); A61K 31/435 (2006.01); A61K 31/436 (2006.01); A61K 47/26 (2006.01); A61K 47/30 (2006.01); A61P 37/06 (2006.01)
CPC (source: EP KR)
A61K 9/2086 (2013.01 - EP); A61K 9/2826 (2013.01 - KR); A61K 9/2853 (2013.01 - KR); A61K 9/2893 (2013.01 - KR); A61K 31/436 (2013.01 - KR); A61K 31/7052 (2013.01 - EP); A61P 1/04 (2018.01 - EP); A61P 3/04 (2018.01 - EP); A61P 3/10 (2018.01 - EP); A61P 9/00 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 11/00 (2018.01 - EP); A61P 11/06 (2018.01 - EP); A61P 11/16 (2018.01 - EP); A61P 17/00 (2018.01 - EP); A61P 17/02 (2018.01 - EP); A61P 17/04 (2018.01 - EP); A61P 17/06 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 21/04 (2018.01 - EP); A61P 25/00 (2018.01 - EP); A61P 27/02 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 31/00 (2018.01 - EP); A61P 31/10 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 35/02 (2018.01 - EP); A61P 37/00 (2018.01 - EP); A61P 37/02 (2018.01 - EP); A61P 37/06 (2018.01 - EP)
Citation (search report)
- [A] US 5352783 A 19941004 - SHAFIEE ALI [US], et al
- [A] EP 0525960 A1 19930203 - AMERICAN HOME PROD [US]
- [A] GB 2278780 A 19941214 - SANDOZ LTD [CH]
- [AD] US 5559121 A 19960924 - HARRISON MAUREEN M [US], et al
- [A] US 5340589 A 19940823 - STETSKO GREGG [US], et al
- [A] EP 0722720 A1 19960724 - AMERICAN HOME PROD [US]
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
EP 0868911 A2 19981007; EP 0868911 A3 20001206; EP 0868911 B1 20020911; AR 012069 A1 20000927; AT E223705 T1 20020915; AU 5838398 A 19980917; AU 723943 B2 20000907; BR 9801120 A 20000111; BR 9801120 B1 20091201; CA 2230748 A1 19980914; CA 2230748 C 20100803; CN 1140268 C 20040303; CN 1197639 A 19981104; CY 2313 B1 20031114; CZ 292949 B6 20040114; CZ 77198 A3 19980916; DE 69807768 D1 20021017; DE 69807768 T2 20030206; DK 0868911 T3 20030120; ES 2183287 T3 20030316; HK 1015677 A1 19991022; HU 224701 B1 20060130; HU 9800573 D0 19980528; HU P9800573 A2 19990628; HU P9800573 A3 20000128; IL 123525 A0 19981030; IL 123525 A 20020310; JP 2009298823 A 20091224; JP 4616426 B2 20110119; JP H10259131 A 19980929; KR 100513919 B1 20060228; KR 19980080222 A 19981125; NZ 329976 A 19991028; PT 868911 E 20021231; RU 2220714 C2 20040110; SG 63824 A1 19990330; SI 0868911 T1 20021231; TW 550091 B 20030901; UA 56143 C2 20030515; ZA 982112 B 19990913
DOCDB simple family (application)
EP 98301716 A 19980309; AR P980101154 A 19980313; AT 98301716 T 19980309; AU 5838398 A 19980313; BR 9801120 A 19980313; CA 2230748 A 19980302; CN 98108244 A 19980313; CY 0300006 A 20030127; CZ 77198 A 19980313; DE 69807768 T 19980309; DK 98301716 T 19980309; ES 98301716 T 19980309; HK 99100627 A 19990212; HU P9800573 A 19980313; IL 12352598 A 19980303; JP 2009230289 A 20091002; JP 6288598 A 19980313; KR 19980008439 A 19980313; NZ 32997698 A 19980317; PT 98301716 T 19980309; RU 98104946 A 19980313; SG 1998000512 A 19980312; SI 9830250 T 19980309; TW 87103043 A 19980303; UA 98031295 A 19980313; ZA 982112 A 19980312